Skip to main content

Janelle Anderson is a Managing Partner at CTI Life Sciences, a VC firm that funds early- to mid-stage companies developing therapeutics and other medical innovations.

Before CTI, Dr. Anderson was the Managing Director of the MRL Venture Fund, the corporate venture arm of Merck focused on early-stage science and breakthrough therapeutics. She spent several years prior at Merck working for Biologics and Vaccines R&D, various roles within Finance, and as the Business Director for the newly formed, virtual External Basic Research organization. Dr. Anderson had previously been at Carrot Capital Healthcare Ventures, a seed-stage VC firm based in Manhattan, where she built startup companies as an Entrepreneur-in-Residence. In this position she served as Acting CEO of the medical device company Access Scientific from its earliest stages of inception.

Prior to becoming a venture capitalist, she was a management consultant at The Boston Consulting Group where she created growth strategies, drove operational excellence, and analyzed portfolios for pharma, biotech, and other healthcare clients.

Dr. Anderson received a B.Sc. (Honours) in Chemistry from McGill University and an A.M. and Ph.D. in Chemistry from the Whitesides lab at Harvard University.